Tetraphase Pharmaceuticals Cash Flow - Annual (NASDAQ:TTPH)

Add to My Stocks
$2.92 $0.24 (7.59%) TTPH stock closing price Sep 21, 2018 (Closing)

The Tetraphase Pharmaceuticals cash flow statement helps investors understand how well the company is managing its cash flows. Financials statements like the Tetraphase Pharmaceuticals income statement and Tetraphase Pharmaceuticals balance sheet show that the company has profits and debt, while the cash flow statement provides details of cash flow movments. Tetraphase Pharmaceuticals cash flow analysis is possible because this statement breaks down how balance sheet accounts and income statement items affect cash and cash equivalents. Tetraphase Pharmaceuticals had cash and cash equivalents of $142.08M at the beginning of the year and $136.41M at year end for 2017. TTPH decrease in investments stood at a value of $-0.77M for the latest year 2017.

View details of Tetraphase Pharmaceuticals cash flows for latest & last 10 financial years
show more
View Previous Years
View Next Years
Fiscal year is Jan - Dec2017201620152014201320122011
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow-------
Net Increase (Decrease) in Assets Liabilities4.3M--5.46M3.42M3.42M-2.25M-
Cash From (used in) Discontinued Operations-------
Other Adjustments Net11.96M13.14M11.66M5.34M1.23M--
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-0.77M-0.39M-0.83M-0.19M-0.12M-0.05M-0.06M
Acquisition Disposition of Subsidiaires-------
Increase (Decrease) in Investments-------
Other Cash Inflow (Outflow) from Investment Activities-------
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares93.14M-167.06M82.27M119.5M--
Issuance (Repayment) of Debt Securities---4.64M-6.12M-1.23M4M7.94M
Increase (Decrease) in Bank & Other Borrowings-------
Payment of Dividends & Other Cash Distributions-------
Other Cash from (used by) Financing Activities------1.34M-0.17M
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash-------
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year142.08M205.91M121.04M102.71M9.07M22.45M34.58M
Cash & Equivalents at Year End136.41M142.08M205.91M121.04M102.71M9.07M22.45M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years

Tetraphase Pharmaceuticals stock price history provides insight into historical stock price fluctuations, and Tetraphase Pharmaceuticals stock comparison chart enables peer comparison. Some of the key terms used in the statement of cash flows are:

  • Tetraphase Pharmaceuticals saw a positive change in Net Change in Cash and Cash Equivalents of $-5.67M in 2017. Apart from the Tetraphase Pharmaceuticals stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Tetraphase Pharmaceuticals reported a negative operating cash flow of $-98.05M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: Tetraphase Pharmaceuticals used $-0.77M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $93.14M for Tetraphase Pharmaceuticals.

Key Financial Ratios For Tetraphase Pharmaceuticals Cash Flow